ETS-related gene (ERG) expression as a predictor of oncological outcomes in patients with high-grade prostate cancer treated with primary androgen deprivation therapy: a cohort study.

Saved in:
Bibliographic Details
Title: ETS-related gene (ERG) expression as a predictor of oncological outcomes in patients with high-grade prostate cancer treated with primary androgen deprivation therapy: a cohort study.
Authors: Rezk M; NIHR Biomedical Research Centre, Kings College London, London, UK.; Intensive Care Unit, Torbay and South Devon NHS Foundation Trust, Torquay, UK., Chandra A; Department of Histopathology and Cytology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Addis D; Department of Histopathology and Cytology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Møller H; Department of Cancer Epidemiology & Populational Health, Kings College London, London, UK., Youssef M; General Surgery Department, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK.; Surgical Oncology Department, National Cancer Institute, Cairo, Egypt., Dasgupta P; NIHR Biomedical Research Centre, Kings College London, London, UK., Yamamoto H; Department of Urology, Guy's and St Thomas' NHS Foundation Trust, London, UK.; Department of Urology, Maidstone Hospital, Maidstone, UK.
Source: BMJ open [BMJ Open] 2019 Mar 08; Vol. 9 (3), pp. e025161. Date of Electronic Publication: 2019 Mar 08.
Publication Type: Journal Article
Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-6055 (Electronic) Linking ISSN: 20446055 NLM ISO Abbreviation: BMJ Open Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2044-6055
DOI:10.1136/bmjopen-2018-025161